long intergenic non-protein coding RNA 2178Genealiases: []
Q-omics provides the consensus-scored LINC02178 profile across patient tissues and cancer cell-line models. LINC02178 expression is associated with patient survival in 21 of 34 cancer types, with the highest sampling consensus in LUAD. Among the 18 cancer types available for tumor–normal comparison, LINC02178 is differentially expressed in 11, with the highest sampling consensus in UCEC. Additionally, LINC02178 RNA expression shows 10,600 significant protein co-abundance associations, with the highest sampling consensus in HNSC. Together, these results highlight LUAD, UCEC, and HNSC as cancer lineages where LINC02178 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02178 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02178 survival associations across molecular data types. LINC02178 RNA expression shows survival associations in the most cancer types (21). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02178 RNA expression–survival associations across cancer types. High LINC02178 expression shows unfavorable associations in LUAD, KICH, THYM, PAAD, BRCA and UVM. The LUAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify LUAD as the clearest survival context for LINC02178 RNA expression.
This table summarizes LINC02178 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 11. The strongest signals are observed in UCEC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02178. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02178 shows lower tumor expression in KIRC and higher tumor expression in UCEC, LUSC, BRCA, LUAD and BLCA. The UCEC box plot shows higher LINC02178 RNA expression in tumor versus normal tissue (log2 FC = +0.867, t-test p = .010).
This table shows molecular features associated with LINC02178 in patient tissues and cancer cell lines. In patient samples, LINC02178 shows the broadest associations at the RNA and protein expression levels, with HNSC recurring as the lineage with the largest associated feature set.
